Original Research
Published on 14 Nov 2025
CD302 regulates the malignant phenotypes of lung adenocarcinoma as a tumor suppressor gene
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1601706
- 818 views
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,929 articles
articles
Mini Review
Published on 13 Nov 2025
AI-based prediction of pathological risk factors in lung adenocarcinoma from CT imaging: bridging innovation and clinical practice
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1687360
- 954 views
Original Research
Published on 10 Nov 2025
18F-FAPI-04 PET/CT in the evaluation of ground-glass nodules less than 3 cm in diameter comparing to 18F-FDG PET/CT
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1605678
- 999 views
Original Research
Published on 07 Nov 2025
Predicting immunotherapy response in stage III-IV non-small cell lung cancer using integrated radiomics and clinical features
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1669469
- 964 views
Correction
Published on 07 Nov 2025
Correction: Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1720422
- 458 views
Original Research
Published on 06 Nov 2025
Analysis of short-term clinical efficacy and immune function changes of advanced non-small cell lung cancer after radiotherapy or chemotherapy under CT-guided 125I seed implantation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1667205
- 662 views
Case Report
Published on 06 Nov 2025
Case Report: Pitfalls in anatomic pathology and clinical oncology: a case of misdiagnosed pulmonary Ewing sarcoma as SCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1635424
- 950 views
Original Research
Published on 04 Nov 2025
MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1642999
- 872 views
Case Report
Accepted on 03 Nov 2025
CASE REPORT: MUCOEPIDERMOID CARCINOMA OF THE LUNG, A CHALLENGING DIAGNOSIS OF AN UNUSUAL CASE
in Thoracic Oncology
Frontiers in Oncology
- 198 views
Original Research
Published on 31 Oct 2025
To predict the spread through air spaces in lung adenocarcinoma using radiomic features from different regions of part-solid nodules: a multicenter study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1700843
- 905 views
Original Research
Published on 31 Oct 2025
Preoperative plasma fibrinogen combined with the platelet-to-lymphocyte ratio (F-PLR) serves as a prognostic indicator in patients with non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1587443
- 703 views
Original Research
Published on 30 Oct 2025
Predicting EGFR gene mutation in lung adenocarcinoma using spectral CT combined with AI parameters: a diagnostic accuracy study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1611759
- 1,116 views
Original Research
Published on 29 Oct 2025
Fusion of CT radiomics and autoantibody biomarkers for enhanced prediction of lung cancer diagnosis: a comprehensive study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1591156
- 1,104 views
Original Research
Published on 29 Oct 2025
Development and validation of machine learning models for predicting STAS in stage I lung adenocarcinoma with part-solid and solid nodules: a two-center study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1682633
- 917 views
Case Report
Published on 28 Oct 2025
Long-term survival following multimodal therapy for lung cancer with hepatic metastasis: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1663079
- 1,275 views
Case Report
Published on 27 Oct 2025
Case Report: Evolution and targeted therapy of an EGFR-mutant large-cell neuroendocrine carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1599765
- 1,328 views
Original Research
Published on 27 Oct 2025
Preoperative absolute neutrophil count: a potential indicator for prognosis in carcinoembryonic antigen normal stage I non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1632597
- 667 views
Original Research
Published on 27 Oct 2025
Conformal sublobar electroresection with volume optimization achieves greater parenchymal preservation than stapler in wedge resection: a volumetric analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1657405
- 698 views
Brief Research Report
Published on 27 Oct 2025
Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1675386
- 1,342 views
Review
Published on 27 Oct 2025
A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1646608
- 2,271 views
Review
Published on 23 Oct 2025
Advances in modelling the risk of benign and malignant lung nodules
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1648548
- 1,023 views
Original Research
Published on 23 Oct 2025
Real-world survival patterns and multimodal therapy utilization in small cell lung cancer: a retrospective cohort study in a Chinese countryside hospital
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1636533
- 1,221 views
Original Research
Published on 22 Oct 2025
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1681420
- 2,551 views
Original Research
Published on 22 Oct 2025
Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1647385
- 1,278 views